Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Researchers found a way to hijack devices through Zoom screen sharing

    August 13, 2026

    Birmingham Green Party councillor charged with assaulting five people

    August 13, 2026

    Solar eclipse sends Europe stays above $1,000 a night

    August 13, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Investing»Why is Kemira stock plunging today? By Investing.com
    Investing

    Why is Kemira stock plunging today? By Investing.com

    franperez66q@protonmail.comBy franperez66q@protonmail.comJune 10, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    Investing.com — stock is down 7.3% during today’s session after the Finnish chemicals company issued a profit warning and lowered its 2026 profitability outlook, citing higher raw material and logistics costs linked to the prolonged conflict in Iran.

    The company now expects 2026 revenue of €2.6 billion to €3.0 billion and operative EBITDA of €400 million to €500 million.

    As a result, the stock touched a new 52-week low of €15.29 intraday as persistent selling pressure from today’s news as well as a weak Q1 2026 earnings report continues to erode investor confidence in the Finnish specialty chemicals company.

    The April 24 interim results revealed that first-quarter EPS of €0.29 missed the consensus estimate of approximately €0.32, while revenue fell 4% year-on-year to €677.3 million and operative EBITDA dropped 13% to €117.3 million — with the margin shrinking to 17.3% from 19.1% in the prior-year period.

    CEO Antti Salminen described the quarter as dominated by a “really weak global economy” and escalating geopolitical tensions that created strong headwinds across the business, particularly in the Packaging & Hygiene Solutions segment, where the operative EBITDA margin compressed to 10.1% from 12.0%. Adding to the pressure, analysts have been trimming their price targets in the aftermath of the results, with Danske Bank issuing a downgrade and the consensus target declining from €22.65 to €21.80, reflecting more cautious assumptions on revenue growth and profit margins going forward.

    The broader market context offers little relief, with the NASDAQ declining and the S&P 500 also trading in negative territory today, reinforcing a risk-off tone that tends to disproportionately affect mid-cap industrial and specialty chemicals names.

    Kemira’s full-year 2026 guidance — with a wide revenue range of €2,600–€3,000 million and operative EBITDA of €470–€570 million — has itself been interpreted as a signal of significant uncertainty, as the company also flagged that raw material cost increases (particularly oil derivatives, which represent roughly one-third of its cost base) and ongoing foreign exchange headwinds could further pressure margins.

    The combination of a meaningful earnings miss, deteriorating segment profitability, analyst downgrades, elevated input costs, and a cautious macro environment has created a compounding negative feedback loop for Kemira shares today, pushing the stock to levels not seen in over a year and raising questions about whether the company can return to its operative EBITDA margin target range of 18–21% on a quarterly basis in the near term.

    This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Russia stocks higher at close of trade; MOEX Russia Index up 0.75%

    August 2, 2026

    AstraZeneca and Bristol-Myers Squibb in talks over potential merger – Report

    August 2, 2026

    AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports By Reuters

    August 2, 2026

    Is now the time to buy European equities?

    August 2, 2026

    Saudi Arabia stocks higher at close of trade; Tadawul All Share up 1.10%

    August 2, 2026

    For GLP-1 users, the in-store clothes shopping trip is back

    August 2, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    Researchers found a way to hijack devices through Zoom screen sharing

    August 13, 2026

    Birmingham Green Party councillor charged with assaulting five people

    August 13, 2026

    Solar eclipse sends Europe stays above $1,000 a night

    August 13, 2026

    Google reveals 2026 hardware lineup: Pixel 11, Pixel Watch 5, and Pixel Tag

    August 13, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.